Intermolecular Inc (NASDAQ:IMI) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.13 and traded as high as $1.19. Intermolecular shares last traded at $1.19, with a volume of 584 shares traded.
Separately, ValuEngine upgraded Intermolecular from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st.
The company has a debt-to-equity ratio of 0.43, a quick ratio of 4.74 and a current ratio of 4.74. The business has a 50 day moving average of $1.18 and a two-hundred day moving average of $1.13.
Several hedge funds and other institutional investors have recently modified their holdings of IMI. Susquehanna International Group LLP purchased a new stake in Intermolecular during the 2nd quarter worth about $40,000. Citadel Advisors LLC purchased a new stake in Intermolecular during the 2nd quarter worth about $41,000. Paloma Partners Management Co purchased a new stake in Intermolecular during the 2nd quarter worth about $132,000. Vanguard Group Inc. lifted its holdings in Intermolecular by 145.0% during the 2nd quarter. Vanguard Group Inc. now owns 854,257 shares of the semiconductor company’s stock worth $999,000 after buying an additional 505,600 shares during the last quarter. Finally, HGC Investment Management Inc. purchased a new stake in Intermolecular during the 2nd quarter worth about $774,000. Hedge funds and other institutional investors own 49.29% of the company’s stock.
Intermolecular Company Profile (NASDAQ:IMI)
Intermolecular, Inc engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods.
Read More: Are all No-Load Funds Equal?
Receive News & Ratings for Intermolecular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular and related companies with MarketBeat.com's FREE daily email newsletter.